Hanna D.
- Country
- Sweden
- Department
- Karolinska Universitetssjukhuset
Research Overview
- Phase 3 Randomized Study of Pembrolizumab Versus Platinum-Based Chemotherapy in Mismatch Repair Deficient Advanced or Recurrent Endometrial Carcinoma
- Phase 3 Randomized Double-Blind Study of Niraparib Tosilate Monohydrate Maintenance in Advanced Ovarian Cancer Post-Platinum Chemotherapy Response
- Evaluation of Safety and Tolerability of KAND567 and Carboplatin in Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Data & Insights
Has run more than one trial at 107 of 244 partner sites.
Specializations
Gynecologic Oncology
This investigator specializes in treating various forms of gynecological cancers, with particular emphasis on endometrial cancer management and innovative therapeutic approaches.
- Advanced endometrial cancer treatment
- Recurrent disease management
- Maintenance therapy development
Their research extends to both early-stage and advanced disease states, incorporating novel therapeutic agents.
Ovarian Cancer Research
The investigator focuses on developing treatments for advanced ovarian cancer, including studies of epithelial ovarian cancer, fallopian tube, and primary peritoneal cancers.
- Platinum-based combination therapies
- Maintenance treatment strategies
- Recurrent disease protocols
Their work encompasses comprehensive treatment approaches for various stages of ovarian cancer.
Therapeutic Innovation
The investigator explores targeted therapies and immunotherapy approaches in gynecologic cancers, including evaluation of novel compounds and treatment combinations.
- Immunotherapy applications
- Novel therapeutic agents
- Combination treatment strategies
Their research includes assessment of treatment efficacy through various clinical endpoints and survival measures.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.